Breakthrough for AlzeCure in the development of drugs for nerve pain
AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.
New data from AlzeCure’s phase IIa study show that the drug candidate ACD440 has a significant analgesic effect on pain induced by cold and heat.
– The medical need in this area is immense, not least to find alternatives to opioids. Neuropathic pain is the single largest market segment in pain management, generating over $11 billion in annual revenues. Up to 80 percent of all patients do not get a satisfactory effect with their current treatments, said AlzeCure Pharma’s CEO Martin Jönsson.
AlzeCure is among a handful of companies in the world that develop drugs that target the TRPV1 receptor, whose discovery was awarded the 2021 Nobel Prize in Medicine. The goal is to help people who suffer from nerve pain. In many cases today, there is no other effective treatment available than opioids, which both numb the whole body and can lead to addiction and substance abuse.
How the Stockholm region will become one of the world’s top five life science centres
Region Stockholm is now stepping up its efforts to become one of the world’s five leading centres for life science by 2025. Martin Tegnér leads the project from his newly setup programme office, which will oversee the initiative to completion.
Now more companies are growing together with Bactiguard
Just south of Campus Flemingsberg, three life science companies – Bactiguard, Procella and Smartwise – share the same building. Their proximity to one another makes it possible to combine several different innovations in new forms of treatment.
SMI invites you to a Christmas lunch concert
Stockholm Music Education Institute, SMI invites you to a Christmas percussion concert on December 12. Percussion students and teachers perform a varied program and a porridge lunch with Christmas porridge, ham sandwich, fluff bun, gingerbread and coffee is served for only SEK 60. Lunch is served from 11.30 and the concert starts at 12.
Event: Welcome to our new coworking and meeting place at Campus Flemingsberg
Stockholm aims to become a world-leading life science cluster. To succeed, the city needs expertise, research facilities, cooperation and cross-border meeting places where creative collaborations can occur. Welcome to a launch event where we will shed light on what's needed to set us all on the right path.
